Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3520 ARTÍCULOS , VIENDO DEL 1801 AL 1815

[Braak's hypothesis and non-motor symptoms of Parkinson disease]

Saito Y, Murayama S.

Brain Nerve. 2012 Apr;64(4):444-52.

Molecular insights into Parkinson's disease

Rochet JC, Hay BA, Guo M.

Prog Mol Biol Transl Sci. 2012;107:125-88. doi: 10.1016/B978-0-12-385883-2.00011-4.

Biology of mitochondria in neurodegenerative diseases

Martin LJ.

Prog Mol Biol Transl Sci. 2012;107:355-415. doi: 10.1016/B978-0-12-385883-2.00005-9.

Mitochondrial diseases

Schapira AH.

Lancet. 2012 May 12;379(9828):1825-34. doi: 10.1016/S0140-6736(11)61305-6. Epub 2012 Apr 5.

Inhibitors of Catechol-O-Methyltransferase

Barrow JC.

CNS Neurol Disord Drug Targets. 2012 May;11(3):324-32. doi: 10.2174/187152712800672517.

Role of catechol-O-methyltransferase (COMT)-dependent processes in Parkinson's disease and L-DOPA treatment

Espinoza S, Manago F, Leo D, Sotnikova TD, Gainetdinov RR.

CNS Neurol Disord Drug Targets. 2012 May;11(3):251-63. doi: 10.2174/187152712800672436.

Catechol-o-methyltransferase and Alzheimer's disease: a review of biological and genetic findings

Serretti A, Olgiati P.

CNS Neurol Disord Drug Targets. 2012 May;11(3):299-305. doi: 10.2174/187152712800672472.

Redox sensitivity of tyrosine hydroxylase activity and expression in dopaminergic dysfunction

Di Giovanni G, Pessia M, Di Maio R.

CNS Neurol Disord Drug Targets. 2012 Jun 1;11(4):419-29. doi: 10.2174/187152712800792938.

Motor and non-motor features of Parkinson's disease - a review of clinical and experimental studies

Lima MM, Martins EF, Delattre AM, Proenca MB, Mori MA, Carabelli B, Ferraz AC.

CNS Neurol Disord Drug Targets. 2012 Jun 1;11(4):439-49. doi: 10.2174/187152712800792893.

Mitochondria as an easy target to oxidative stress events in Parkinson's disease

Reale M, Pesce M, Priyadarshini M, Kamal MA, Patruno A.

CNS Neurol Disord Drug Targets. 2012 Jun 1;11(4):430-8. doi: 10.2174/187152712800792875.

New agents promote neuroprotection in Parkinson's disease models

Santos CM.

CNS Neurol Disord Drug Targets. 2012 Jun 1;11(4):410-8. doi: 10.2174/187152712800792820.

Targeting Parkinson's - tyrosine hydroxylase and oxidative stress as points of interventions

Khan MS, Tabrez S, Priyadarshini M, Priyamvada S, Khan MM.

CNS Neurol Disord Drug Targets. 2012 Jun 1;11(4):369-80. doi: 10.2174/187152712800792848.

A synopsis on the role of tyrosine hydroxylase in Parkinson's disease

Tabrez S, Jabir NR, Shakil S, Greig NH, Alam Q, Abuzenadah AM, Damanhouri GA, Kamal MA.

CNS Neurol Disord Drug Targets. 2012 Jun 1;11(4):395-409. doi: 10.2174/187152712800792785.

The function of tyrosine hydroxylase in the normal and Parkinsonian brain

Tolleson C, Claassen D.

CNS Neurol Disord Drug Targets. 2012 Jun 1;11(4):381-6. doi: 10.2174/187152712800792794.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias